Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patient-reported psoriasis signs and symptoms improvement was significantly better in those treated with deucravacitinib over placebo and apremilast, according to two clinical trials presented at the EADV Congress virtual meeting.“Deucravacitinib is a novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor that binds to the regulatory domain with high specificity,” April Armstrong,
Measurement-based care decreased depression severity, promoted remission and improved medication adherence among patients with depressive disorders treated with pharmacotherapy, according to a study.“Measurement-based care (MBC) is an evidence-based practice that provides a systematic framework for routine outcome monitoring and has demonstrated benefit in treating a range of psychiatric
While the COVID-19 pandemic has put an incredible burden on all health care workers, it has also fueled a resurgence of anti-Asian racism in the U.S. and highlighted disparities in health care research and opportunities for Asian Americans. Patricia Mae G. Santos, MD, MS, a resident physician at the Memorial Sloan Kettering Cancer Center in New York, and colleagues argued in a recent
HIV self-testing kits were easy to use and widely accepted by people who inject drugs, who reported a desire to know their HIV status and to continuously be able to test, according to preliminary findings from a study presented at IDWeek. “People who inject drugs (PWID) are at significantly increased risk of acquiring HIV compared to the general population. Although health departments and
Surrogate insulin resistance measures positively predicted incident major depressive disorder among adults with no depression or anxiety disorder history, according to a study in American Journal of Psychiatry.“Several studies showed an association between insulin resistance and depression,” Kathleen T. Watson, PhD, of the department of psychiatry and behavioral sciences at Stanford